The Massachusetts Institute of Technology (MIT) received a $420,061 Project Grant award from the National Science Foundation (NSF) Division of Chemical, Bioengineering, Environmental, and Transport Systems on August 1, 2021 to develop nanosensor chemical cytometry (NCC) technologies in support of cellular therapeutics through July 31, 2024.
The NSF award supports MIT's work under the Engineering (47.041) federal grant program, which seeks to foster innovation and excellence in engineering research. Specifically, MIT will work to develop NCC, a nanotechnology that uses sensors to analyze individual cells, to help advance cellular therapies. NCC has the potential to improve cell-based therapies by enabling high-throughput, multi-parameter analysis of single cells. MIT's work under this three-year Project Grant from NSF aims to support the development of new cellular therapeutic approaches.
Generated 1/6/24, 7:41 PM